[ad_1]
Germ Alzheimer's New Quest Campaign Calls on NIH to Allocate $ 230 Million for Alzheimer's Research
Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, invites you to join a campaign calling for the National Institutes of Health (NIH) to allocate "10% for germs".
Demand that NIH allocate at least 10% of their $ 2.3 billion budget to Alzheimer's disease research to other deserving scientists studying the role of bacteria, viruses, and viruses. 39, other infectious agents.
This is an obstacle because the NIH holds the near-monopoly of large sums for Alzheimer research.
NAPLES, Florida (PRWEB) November 23, 2018
Alzheimer's Germ Quest, Inc., an independent advocacy organization for Alzheimer's disease research, has launched "10% for Germs," a popular campaign among citizens, patients and caregivers to require National Institutes of Health (NIH) that they immediately allocate $ 230 million to research grants to determine the role of the germs responsible for Alzheimer's disease, announced its CEO, Leslie Norins , MD, Ph.D.
The "10%" indicates that $ 230 million represents 10% of the $ 2.3 million Congress, which Congress recently awarded to the NIH for research work on this disease. On the basis of past models, little investment would be devoted to studying the role of bacteria, viruses and other infectious agents.
"In the past twelve months, many top scientists have said that the hottest new leads are that Alzheimer's disease is caused by infectious agents. But the investigators are deadlocked because the NIH will not fund this research significantly, "he said.
"This is an obstacle because the NIH holds the near-monopoly of large sums for Alzheimer's research. Its budget this year is $ 2.3 billion, while the second prize, the Alzheimer's Association, awards only $ 40 million. This NIH research money is 57.5 times larger and represents 98.3% of their combined total.
Dr. Norins says that another problem is a mismatch of judgment. He proposes a cooking analogy. "Experts judge ryebreads are not experts in judging wedding cakes."
"Until now, most of the scientists at NIH's grant selection juries for Alzheimer's were experts on former suspects, amyloid and tau brain proteins. Let's call these ryebreads. Few of them are competent to judge infectious agents, which I will call wedding cakes. It goes without saying that the excellent wedding cake proposals have not been awarded grants because they are not real pearls. "
He says the NIH needs to quickly bring together an expert from the jury to judge Alzheimer's disease in the assessment of "wedding cakes," that is, grant proposals to investigate infectious agents. Pay $ 230 million, or 10% of the $ 2.3 billion budget, to meritorious funds. "That still leaves 90% of the NIH, or $ 2.1 billion, for research on the traditional topics that it has privileged."
"Change must come from the top," says Dr. Norins, nominating Congress and the NIH director. He says, "At lower levels, the cult of amyloid / tau is rooted and it will not add research on infectious agents without the insistence of superiors."
Dr. Norins urges concerned citizens and families of patients to send an e-mail to their congressional leader and NIH director Dr. Francis Collins ([email protected]) to request the allocation of $ 230 million of dollars. An explanatory video and a national advertisement have also been published.
Alzheimer's disease affects about five million Americans and 303 people die each day. His cause is unknown and there is still no cure, 112 years after his first description by Dr. Alois Alzheimer.
Alzheimer's Germ Quest, Inc. is a public-interest corporation headquartered in Naples, Florida. He sponsors the $ 1 Million Challenge Challenge for a scientist who proves that a germ triggers Alzheimer's disease. Donations are neither solicited nor accepted.
Contact Author
Dr. Leslie Norins, Quest for Alzheimer's Germs
239-649-1346
Email> Visit the website
Media
Require NIH to spend 10% of its budget studying the role of bacteria, viruses and other infectious agents in Alzheimer's disease.
[ad_2]
Source link
